Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation

Lasers Med Sci. 2012 May;27(3):621-7. doi: 10.1007/s10103-011-1006-y. Epub 2011 Oct 16.

Abstract

In this study, the aim is to investigate the cytologic effects of inflammatory bone cells after in vitro low-level laser therapy (LLLT). A human osteosarcoma cell line (MG63) was cultured, infected with lipopolysaccharide (LPS) and exposed to low-level laser treatment at 5 or 10 J/cm(2) using a 920 nm diode laser. MG63 cell attachment was observed under a microscope, and cell viability was quantified by mitochondrial colorimetric assay (MTT). LPS-treated MG63 cells were irradiated with LLLT, and the inflammatory markers iNOS, TNF-α and IL-1, were analyzed by reverse transcription polymerase chain reaction (RT-PCR) and Western blot. The data were collected and analyzed by one-way analysis of variance (ANOVA); p < 0.05 indicated a statistically significant difference. Low-level laser treatment on MG63 cells increased their ability to attach and survive. After irradiation, the expression levels of iNOS, TNF-α and IL-1 in LPS-infected MG63 cells decreased over time (p < 0.05).

Conclusions: low-level diode laser treatment increased the MG63 cell proliferative ability and decreased the expression of inflammatory mediators in MG63 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone and Bones / cytology
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism
  • Bone and Bones / radiation effects*
  • Cell Adhesion / radiation effects
  • Cell Line, Tumor
  • Cell Survival / radiation effects
  • Gene Expression / radiation effects
  • Humans
  • Inflammation / prevention & control
  • Interleukin-1 / genetics
  • Lasers, Semiconductor / therapeutic use*
  • Lipopolysaccharides / toxicity
  • Low-Level Light Therapy* / methods
  • Nitric Oxide Synthase Type II / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Interleukin-1
  • Lipopolysaccharides
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • NOS2 protein, human
  • Nitric Oxide Synthase Type II